John Poulos
Net worth: - $ as of 30/05/2026
Net worth: - $ as of 30/05/2026
John Poulos currently works at Faron Pharmaceuticals Oy, as Independent Non-Executive Director from 2017, Memgen, Inc., as Director from 2020, and GNK Advisors, Inc., as President from 2016.
Mr. Poulos also formerly worked at Abbott Pharmaceutical, Inc., as Head-Pharmaceutical Licensing & Acquisitions from 2005 to 2012 and AbbVie Oy, as VP, Head-Business Development & Acquisitions from 2013 to 2016.
Mr. Poulos received his undergraduate degree and Masters Business Admin degree from Indiana University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/12/2025 | 0 ( -.--% ) | - $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Board Member | 15/05/2017 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Director/Board Member | 17/11/2020 |
GNK Advisors, Inc. | President | 31/12/2015 |
| Companies | Position | End |
|---|---|---|
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Corporate Officer/Principal | 31/12/2015 |
Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 31/12/2011 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Health Technology |
Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
GNK Advisors, Inc. |
Select your edition
All financial news and data tailored to specific country editions